Latest Conference

External female catheter could be 1 strategy to reduce the prevalence of CAUTIs.

The research team used single site testing for 1442 (32%) patients with 54 positive (4%) results. Multiple site testing was performed on 3037 (68%) patients and 255 (8%) were positive from at least 1 site tested.

Survey results emphasize the value of educating full-time students with science- and health care-focused majors about vaccines.

De-escalation to monotherapy upon bacteremia resolution did not result in unfavorable outcome differences compared with those who continued combination therapy.

From biosensors to travel screening efforts, here's how DHS is beefing up biodefense.

It's time to use data technology to help tackle epidemics and pandemic preparedness.

Kimberly Claeys, PharmD, discusses the need for more data on rapid diagnostics for gram-negative bloodstream infections.

Develop an exposure plan before a communicable disease event and save yourself time and money.

Research from APIC provides insight into how to strengthen this critical component to patient safety.

Research documents inadequate sanitation at a skilled nursing facility and a long-term acute care facility where an individual with A baumannii infection was treated.

Investigators from the Washington State Department of Health set out to identify ways to leverage technology to increase public awareness of the importance of antimicrobial stewardship.

EMS practiced hand hygiene before patient contact in just 7% of assessments but wore gloves in 100% of observed interactions

As May draws to a close, the Contagion® editorial staff is recapping the trends and top infectious disease news of the month.

Thomas Lodise, PharmD, PhD, discusses why "time to clinical response" is a valuable metric to use in clinical studies.

At MAD-ID 2019, Alison Lew, PharmD, spoke about her research on oral vancomycin prophylaxis to reduce CDI recurrence.

Renee Ackley, PharmD, BCPS, discusses her research ceftazidime/avibactam and meropenem/vaborbactam for treatment of CRE infections.

Does pharmacist presence in an urgent care center have an effect on antibiotic prescribing practices?

Contagion® editor-in-chief Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, recaps his presentations from MAD-ID 2019.

As clinician are growing interested in the use of extended infusion beta-lactams for gram-negative bacteremia, a team of investigators noticed that available data are unclear and solely focus on clinical cure and/or mortality outcomes.

At MAD-ID 2019, Monica V. Mahoney, PharmD, BCPS (AQID), BCIDP, presented a workshop on formulary management strategies in antimicrobial stewardship.

A study found that patients with complicated C diff infections were more likely to have been previously hospitalized with numerically less time between hospitalization and recent C diff episode.

Brandon J. Smith, MD, PharmD, describes a case of a patient who was treated for mycobacterial infection after ground-glass opacity was detected in her lung.

Ryan K. Shields, PharmD, MS, discusses his research presented at MAD-ID 2019 on T2Candida's place in rational antifungal management.

The total number of bed days saved with outpatient oritavancin administration was 683 days throughout the study period.

A team of investigators from the University of North Carolina Medical Center found that oseltamivir prophylaxis did not reduce the rate of influenza within the first year following a lung transplant.

The primary outcome of the study, which seeks to fully assess infection-related clinical outcomes and microbiological cure rates of PZT for ESBL infections, was clearance of the causative organism from index infection site on first follow-up culture.

A study at SUNY Upstate University Hospital found that AUC-based vancomycin monitoring does not result in higher total drug and monitoring cost compared to trough-based monitoring for patients with MRSA bacteremia.

In order for stewardship programs to be successful they must be supported by all of the health system’s stakeholders – but are we forgetting valuable stakeholders?